NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/27/2025
Back to search
Official data from USPTO
ARGULIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARGULIN
ST13
US500000097160775Class
5, 35, 42, 44
Filing
97160775
Registration
7805944
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
05/30/2025
Trademark type
Word
Nice classes
5, 35, 42, 44
Filing date
12/07/2021
Registration date
05/27/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2025
Last transaction
05/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
09
Owner location
Zürich, CH
Examiner
KON, ELISSA
Law office
L60
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Kyon Biotech AG
Representatives
Cassandra L. Wilkinson Head, Johnson, Kachigian & Wilkinson, PC
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for cancer treatmentexcluding for treatment of blood cancers; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for the treatment of obesity; medical and veterinary preparationsanticancer drugs and compounds for treating cancerexcluding for treatment of blood cancersanti-diabetic pharmaceuticals and preparationsanti-obesity pharmaceuticals and preparations
Class 35
Providing consumer information services relating to the selection of medical products
Class 42
Medical and pharmacological research services; research on the subject of pharmaceuticals; scientific investigations for medical purposes; scientific research for medical purposes; development of pharmaceutical preparations and medicines
Class 44
Medical services; medical services in the field of oncology; medical diagnostic testing services; medical clinic services; conducting of medical examinations; medical consultation regarding use and effectiveness of medical products; medical information; medical advisory services; medical analysis servicesmedical analysis services for cancer diagnosis and prognosis; medical services in the field of diabetes; medical care
Publications
History of USPTO decisions and trademark events.
52 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
05/05/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/05/2025
PC.D
PETITION TO DIRECTOR DISMISSED
05/05/2025
APET
ASSIGNED TO PETITION STAFF
05/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/27/2025
EX3G
SOU EXTENSION 3 GRANTED
03/27/2025
EXT3
SOU EXTENSION 3 FILED
03/27/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
03/26/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/26/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/13/2024
EX2G
SOU EXTENSION 2 GRANTED
09/13/2024
EXT2
SOU EXTENSION 2 FILED
09/13/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/20/2024
EX1G
SOU EXTENSION 1 GRANTED
02/19/2024
EXT1
SOU EXTENSION 1 FILED
02/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/19/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/27/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/27/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/27/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/26/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
08/12/2023
OP.T
OPPOSITION TERMINATED NO. 999999
08/12/2023
OP.D
OPPOSITION DISMISSED NO. 999999
08/12/2023
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/27/2023
APET
ASSIGNED TO PETITION STAFF
07/25/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
07/21/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
07/13/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/24/2023
PUBO
PUBLISHED FOR OPPOSITION
01/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
12/19/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/19/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/19/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/19/2022
DMCC
DATA MODIFICATION COMPLETED
12/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2022
ALIE
ASSIGNED TO LIE
12/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/20/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/13/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/13/2022
CNSL
SUSPENSION LETTER WRITTEN
09/13/2022
DOCK
ASSIGNED TO EXAMINER
09/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2021
NWAP
NEW APPLICATION ENTERED
12/10/2021
Continuous trademark protection
Get notified about every new filing that threatens ARGULIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.